Approval · Notice of Compliance 29362 · 2022
AERIUS: Notice of Compliance 29362
Issued November 2, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29362
- Date
- November 2, 2022
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to labelling to match existing approved artwork and Product Monograph update to 2020 format
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AERIUS | Not yet assigned | — |
| AERIUS KIDS | Not yet assigned | — |
Medicinal ingredients
- DESLORATADINE 5 MG per TAB
- DESLORATADINE 0.5 MG per ML